Sorry, you need to enable JavaScript to visit this website.

SUTENT (sunitinib capsules) Health Professional Information

Pfizer recognizes the public concern in relation to COVID-19, which continues to evolve. Click here to learn how we are responding.
Pfizer reconnaît les préoccupations du grand public concernant la situation liée à la COVID-19, qui continue d'évoluer. Cliquez ici pour savoir comment nous avons réagi.

Health Professional Information

SUMMARY PRODUCT INFORMATION

§
not commercially available in Canada
Route of Administration Dosage Form / Strength Clinically Relevant Nonmedicinal Ingredients
Oral Hard Gelatin Capsules 12.5 mg; 25 mg; 37.5§ mg; 50 mg Not applicable
For a complete listing see Dosage Forms, Composition and Packaging section.

What's New

No Current Announcements.

Contact Pfizer Medical Information

Report an Adverse Event
1 866 723-7111